NeoGenomics to Present at Noble Financial's 5th Annual Equity Conference on Monday, June 8th

ralawizewy.wordpress.com
June 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin NGNM) today announced that it will present at the Fiftg Annual Noble Financial Equity Conferenceat 9:15 AM EDT on June 8, 2009 at the Seminole Hard Rock Hote in Hollywood, FL. , the Company's President and Chiefv Scientific Officer will give a presentationregarding NeoGenomics'' market positioning, financial performance, and strategi direction and then answer questionse from the audience. The presentation will be webcast LIVE featuring streaming video and PowerPoint Access is available by logging onto . In a portal to the webcast will be availablew in the Investor Relations section ofthe NeoGenomics' website at .
It is recommended that interested partiess register at least 10 minutes prio to the start of the presentationn to ensure timely access to the About NeoGenomics, Inc. NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer geneticediagnostic testing, the fastest growing segment of the laboratorhy industry. The company's testing services include cytogenetics, fluorescence in-situj hybridization (FISH), flow morphology studies, anatomic pathology and molecular genetic Headquartered inFort Myers, FL, NeoGenomics has labs in Nashville, TN, CA and Fort Myeras and services the needs of pathologists, oncologists, and hospitals throughout the Unite d States.
For additional information about NeoGenomics, visitr . For more news and information on please visit where you can find a fact sheet on the investor presentations, and more. Interested parties can also accesw additional investorrelations material, including an investment profile and an equityy research report, from Hawk Associate s at or from the American Microcaop Institute at . Noblr Financial is a privately-held, full-service capital marketz firm driven by what is oftenm overlooked by otherfirms - uncovering the valuee embedded in the orphaned, undiscovered or misunderstoodc company. The company focuses on converting marker inefficiencies intoprofit opportunities.
Noble Financial supports emerging companied throughstrategic advice, investmenyt banking, market-making, sales trading, comprehensive equity research, and the development of institutional support. Noble Financial's equity conferences - 2009 marka their fifth annual - allow for a uniquew blend of professional and personal interactionm among adiverse cross-sectio n of executives. The company has operatex for 25 years and has officesin Florida, New York City and SOURCE NeoGenomics, Inc.